Switching off malignant mesothelioma: Exploiting the hypoxic microenvironment
2016-01-01 Nabavi, N.; Bennewith, K. L.; Churg, A.; Wang, Y.; Collins, C. C.; Mutti, L.
Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma
2007-01-01 Porta, C.; Mutti, L.; Tassi, G.
High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma
2002-01-01 Bolognesi, C.; Filiberti, R.; Neri, M.; Perrone, E.; Landini, E.; Canessa, P. A.; Simonassi, C.; Cerrano, P. G.; Mutti, L.; Puntoni, R.
Anti-SV40 antibodies as infection markers for assessing additional risk factors in workers previously exposed to asbestos
2004-01-01 Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P. G.; Tognon, M.; Mutti, L.; Puntoni, R.; Cristaudo, A.
Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis
2001-01-01 Strizzi, L.; Vianale, G.; Catalano, A.; Muraro, R.; Mutti, L.; Procopio, A.
Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma
2000-01-01 Di Muzio, M.; Spoletini, L.; Strizzi, L.; Vianale, G.; Fontana, V.; Orengo, M. A.; Tassi, G.; Casalini, A.; Mutti, L.; Procopio, A.
Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma
2007-01-01 Sartore-Bianchi, A.; Gasparri, F.; Galvani, A.; Nici, L.; Darnowski, J. W.; Barbone, D.; Fennell, D. A.; Gaudino, G.; Porta, C.; Mutti, L.
Current treatment options and biology of peritoneal mesothelioma: Meeting summary of the first NIH peritoneal mesothelioma conference
2006-01-01 Hassan, R.; Alexander, R.; Antman, K.; Boffetta, P.; Churg, A.; Coit, D.; Hausner, P.; Kennedy, R.; Kindler, H.; Metintas, M.; Mutti, L.; Onda, M.; Pass, H.; Premkumar, A.; Roggli, V.; Sterman, D.; Sugarbaker, P.; Taub, R.; Verschraegen, C.
Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor
1995-01-01 Gatti, E.; Scagliotti, G. V.; Ferrari, G.; Mutti, L.; Pozzi, E.; Stacchini, A.; Fubini, L.; Aglietta, M.
Serum Mesothelin dosages in follow-up of previously exposed workers
2007-01-01 Foddis, R.; Vivaldi, A.; Filiberti, R.; Puntoni, R.; Mutti, L.; Ambrosino, N.; Chella, A.; Guglielmi, G.; Gattini, V.; Buselli, R.; Perretta, S.; Cristaudo, A.
A molecular epidemiology case control study on pleural malignant mesothelioma
2005-01-01 Bolognesi, C.; Martini, F.; Tognon, M.; Filiberti, R.; Neri, M.; Perrone, E.; Landini, E.; Canessa, P. A.; Ivaldi, G. P.; Betta, P.; Mutti, L.; Puntoni, R.
Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo
2015-01-01 Miluzio, A.; Oliveto, S.; Pesce, E.; Mutti, L.; Murer, B.; Grosso, S.; Ricciardi, S.; Brina, D.; Biffo, S.
Insight into glucocorticoid receptor signalling through interactome model analysis
2017-01-01 Bakker, E.; Tian, K.; Mutti, L.; Demonacos, C.; Schwartz, J. -M.; Krstic-Demonacos, M.
Study of the combined role of asbestos and SV40 in the pathogenesis of malignant mesothelioma
2004-01-01 Cristaudo, A.; Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P. G.; Tognon, M.; Mutti, L.; Puntoni, R.
Expression of intercellular adhesion molecule-1 (ICAM-1) by reactive mesothelial cells in pleural effusions
1993-01-01 Mutti, L.; Piacenza, A.; Valenti, V.; Castagneto, B.; Betta, P. G.
Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone
2003-01-01 Valle, M. T.; Porta, C.; Megiovanni, A. M.; Libener, R.; Mele, L.; Gaudino, G.; Strizzi, L.; Guida, R.; Toma, S.; Mutti, L.
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation
2010-01-01 Favoni, R. E.; Pattarozzi, A.; Lo Casto, M.; Barbieri, F.; Gatti, M.; Paleari, L.; Bajetto, A.; Porcile, C.; Gaudino, G.; Mutti, L.; Corte, G.; Florio, T.
Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines
2002-01-01 Toma, S.; Colucci, L.; Scarabelli, L.; Scaramuccia, A.; Emionite, L.; Betta, P. G.; Mutti, L.
Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase
2005-01-01 Ramos-Nino, M. E.; Vianale, G.; Sabo-Attwood, T.; Mutti, L.; Porta, C.; Heintz, N.; Mossman, B. T.
Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas
1998-01-01 Rizzo, P.; Di Resta, I.; Stach, R.; Mutti, L.; Picci, P.; Kast, W. M.; Pass, H. I.; Carbone, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Switching off malignant mesothelioma: Exploiting the hypoxic microenvironment | 1-gen-2016 | Nabavi, N.; Bennewith, K. L.; Churg, A.; Wang, Y.; Collins, C. C.; Mutti, L. | |
| Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma | 1-gen-2007 | Porta, C.; Mutti, L.; Tassi, G. | |
| High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma | 1-gen-2002 | Bolognesi, C.; Filiberti, R.; Neri, M.; Perrone, E.; Landini, E.; Canessa, P. A.; Simonassi, C.; Cerrano, P. G.; Mutti, L.; Puntoni, R. | |
| Anti-SV40 antibodies as infection markers for assessing additional risk factors in workers previously exposed to asbestos | 1-gen-2004 | Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P. G.; Tognon, M.; Mutti, L.; Puntoni, R.; Cristaudo, A. | |
| Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis | 1-gen-2001 | Strizzi, L.; Vianale, G.; Catalano, A.; Muraro, R.; Mutti, L.; Procopio, A. | |
| Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma | 1-gen-2000 | Di Muzio, M.; Spoletini, L.; Strizzi, L.; Vianale, G.; Fontana, V.; Orengo, M. A.; Tassi, G.; Casalini, A.; Mutti, L.; Procopio, A. | |
| Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma | 1-gen-2007 | Sartore-Bianchi, A.; Gasparri, F.; Galvani, A.; Nici, L.; Darnowski, J. W.; Barbone, D.; Fennell, D. A.; Gaudino, G.; Porta, C.; Mutti, L. | |
| Current treatment options and biology of peritoneal mesothelioma: Meeting summary of the first NIH peritoneal mesothelioma conference | 1-gen-2006 | Hassan, R.; Alexander, R.; Antman, K.; Boffetta, P.; Churg, A.; Coit, D.; Hausner, P.; Kennedy, R.; Kindler, H.; Metintas, M.; Mutti, L.; Onda, M.; Pass, H.; Premkumar, A.; Roggli, V.; Sterman, D.; Sugarbaker, P.; Taub, R.; Verschraegen, C. | |
| Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor | 1-gen-1995 | Gatti, E.; Scagliotti, G. V.; Ferrari, G.; Mutti, L.; Pozzi, E.; Stacchini, A.; Fubini, L.; Aglietta, M. | |
| Serum Mesothelin dosages in follow-up of previously exposed workers | 1-gen-2007 | Foddis, R.; Vivaldi, A.; Filiberti, R.; Puntoni, R.; Mutti, L.; Ambrosino, N.; Chella, A.; Guglielmi, G.; Gattini, V.; Buselli, R.; Perretta, S.; Cristaudo, A. | |
| A molecular epidemiology case control study on pleural malignant mesothelioma | 1-gen-2005 | Bolognesi, C.; Martini, F.; Tognon, M.; Filiberti, R.; Neri, M.; Perrone, E.; Landini, E.; Canessa, P. A.; Ivaldi, G. P.; Betta, P.; Mutti, L.; Puntoni, R. | |
| Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo | 1-gen-2015 | Miluzio, A.; Oliveto, S.; Pesce, E.; Mutti, L.; Murer, B.; Grosso, S.; Ricciardi, S.; Brina, D.; Biffo, S. | |
| Insight into glucocorticoid receptor signalling through interactome model analysis | 1-gen-2017 | Bakker, E.; Tian, K.; Mutti, L.; Demonacos, C.; Schwartz, J. -M.; Krstic-Demonacos, M. | |
| Study of the combined role of asbestos and SV40 in the pathogenesis of malignant mesothelioma | 1-gen-2004 | Cristaudo, A.; Foddis, R.; Vivaldi, A.; Buselli, R.; Gattini, V.; Guglielmi, G.; Cosentino, F.; Ottenga, F.; Ciancia, E.; Libener, R.; Filiberti, R.; Neri, M.; Betta, P. G.; Tognon, M.; Mutti, L.; Puntoni, R. | |
| Expression of intercellular adhesion molecule-1 (ICAM-1) by reactive mesothelial cells in pleural effusions | 1-gen-1993 | Mutti, L.; Piacenza, A.; Valenti, V.; Castagneto, B.; Betta, P. G. | |
| Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone | 1-gen-2003 | Valle, M. T.; Porta, C.; Megiovanni, A. M.; Libener, R.; Mele, L.; Gaudino, G.; Strizzi, L.; Guida, R.; Toma, S.; Mutti, L. | |
| Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation | 1-gen-2010 | Favoni, R. E.; Pattarozzi, A.; Lo Casto, M.; Barbieri, F.; Gatti, M.; Paleari, L.; Bajetto, A.; Porcile, C.; Gaudino, G.; Mutti, L.; Corte, G.; Florio, T. | |
| Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines | 1-gen-2002 | Toma, S.; Colucci, L.; Scarabelli, L.; Scaramuccia, A.; Emionite, L.; Betta, P. G.; Mutti, L. | |
| Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase | 1-gen-2005 | Ramos-Nino, M. E.; Vianale, G.; Sabo-Attwood, T.; Mutti, L.; Porta, C.; Heintz, N.; Mossman, B. T. | |
| Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas | 1-gen-1998 | Rizzo, P.; Di Resta, I.; Stach, R.; Mutti, L.; Picci, P.; Kast, W. M.; Pass, H. I.; Carbone, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista38797
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa29
- 2020 - 202610567
- 2010 - 201912538
- 2000 - 20098046
- 1990 - 19995281
- 1980 - 19892072
- 1970 - 1979262
- 1966 - 19694
Editore
- EDP Sciences2
- Eliseo Ranzi, Katharina Kohse-Höi...2
- Humana Press Inc.2
- Wiley Online Library2
- Brill1
- Cambridge University Press: 20111
- Edizioni dell'U.M.I.1
- Elsevier1
- GIOVANNI COSTA1
- IFIP1
Rivista
- PHYSICAL REVIEW LETTERS179
- PLOS ONE150
- IEEE TRANSACTIONS ON ELECTROMAGNE...141
- L'INDUSTRIA DELLE COSTRUZIONI140
- APPLIED SCIENCES137
- PHYSICAL REVIEW. B, CONDENSED MAT...135
- INTERNATIONAL JOURNAL OF MOLECULA...131
- SCIENTIFIC REPORTS125
- TRANSPLANTATION PROCEEDINGS118
- ENERGIES106
Serie
- METHODS IN MOLECULAR BIOLOGY2
Keyword
- Humans1211
- Female618
- Male577
- Adult341
- Italy311
- Middle Aged300
- Aged247
- COVID-19240
- Neurology (clinical)227
- Child212
Lingua
- eng27811
- ita5263
- fre99
- spa97
- ger42
- lat9
- pol7
- por6
- rus6
- enm5
Accesso al fulltext
- no fulltext27069
- open8257
- restricted2454
- reserved922
- partially open90
- mixed4
- embargoed3